… Oral mucositis is a significant problem in patients treated with cytostatic drugs or radiation
therapy… The frequency of this complication is estimated to range from 40% of those receiving …

… The incidence of oral mucositis ranges from 15%–40% in patients receiving … of oral mucositis
has evolved and now guides practice. Assessment tools to measure the level of mucositis …

… This review primarily assesses the prevention of chemotherapy-induced oral mucositis,
because there was only 1 study that included patients receiving radiotherapy to the head and …

… therapy (wavelength around 632.8 nm) can be used to prevent oral mucositis in patients
undergoing radiotherapy, without concomitant chemotherapy, for head and neck cancer (Level …

… Oral mucositis (OM) is a limiting factor in the treatment of patients suffering from head and
neck squamous cell carcinoma (HNSCC) who undergo chemoradiotherapy. Its pathobiology is …

… for the treatment of cancer and improved survival rates and consequent cases of oral mucositis.
… of interventions for mucositis prevention is very useful: it indicates where the 27 different …

… of quercetin, it may prevent or treat OM. This study assessed the efficacy of quercetin in
preventing and treating chemotherapy induced oral mucositis in haematologic malignancies. …

… with the purpose of the prevention of oral mucositis was the reason why oral mucositis in the
… Taking into account, risk factors associated with the development of oral mucositis patients …

… This review and meta-analysis evaluates the role that anti-inflammatory mouthwashes have
in preventing or reducing oral mucositis associated with chemotherapy and radiation therapy…

… The search terms used for medical subject heading were 'oral mucositis' and 'new treatments
of mucositis'. Unfortunately, there is not a single method which is capable of preventing or …